π VC round data is live in beta, check it out!
- Public Comps
- Alpha Tau Medical
Alpha Tau Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Alpha Tau Medical and similar public comparables like Bioventus, Synektik, Sunmax Biotechnology, MedicalSystem Technology and more.
Alpha Tau Medical Overview
About Alpha Tau Medical
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiationβs limited range. The company derives maximum revenue from Israel.
Founded
2015
HQ

Employees
125
Website
Financials (LTM)
EV
$650M
Alpha Tau Medical Financials
Alpha Tau Medical reported last 12-month revenue of $381K and negative EBITDA of ($44M).
In the same LTM period, Alpha Tau Medical generated $89K in gross profit, ($44M) in EBITDA losses, and had net loss of ($44M).
Revenue (LTM)
Alpha Tau Medical P&L
In the most recent fiscal year, Alpha Tau Medical reported revenue of β and EBITDA of ($41M).
Alpha Tau Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $381K | XXX | β | XXX | XXX | XXX |
| Gross Profit | $89K | XXX | β | XXX | XXX | XXX |
| Gross Margin | 23% | XXX | β | XXX | XXX | XXX |
| EBITDA | ($44M) | XXX | ($41M) | XXX | XXX | XXX |
| EBITDA Margin | (11594%) | XXX | β | XXX | XXX | XXX |
| EBIT Margin | (11631%) | XXX | β | XXX | XXX | XXX |
| Net Profit | ($44M) | XXX | ($43M) | XXX | XXX | XXX |
| Net Margin | (11457%) | XXX | β | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Alpha Tau Medical Stock Performance
Alpha Tau Medical has current market cap of $709M, and enterprise value of $650M.
Market Cap Evolution
Alpha Tau Medical's stock price is $8.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $650M | $709M | 0.0% | XXX | XXX | XXX | $-0.48 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAlpha Tau Medical Valuation Multiples
Alpha Tau Medical trades at 1707.0x EV/Revenue multiple, and (14.7x) EV/EBITDA.
EV / Revenue (LTM)
Alpha Tau Medical Financial Valuation Multiples
As of April 19, 2026, Alpha Tau Medical has market cap of $709M and EV of $650M.
Equity research analysts estimate Alpha Tau Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Alpha Tau Medical has a P/E ratio of (16.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $709M | XXX | $709M | XXX | XXX | XXX |
| EV (current) | $650M | XXX | $650M | XXX | XXX | XXX |
| EV/Revenue | 1707.0x | XXX | β | XXX | XXX | XXX |
| EV/EBITDA | (14.7x) | XXX | (15.9x) | XXX | XXX | XXX |
| EV/EBIT | (14.7x) | XXX | (15.4x) | XXX | XXX | XXX |
| EV/Gross Profit | 7340.5x | XXX | β | XXX | XXX | XXX |
| P/E | (16.3x) | XXX | (16.6x) | XXX | XXX | XXX |
| EV/FCF | β | XXX | (19.8x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Alpha Tau Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Alpha Tau Medical Margins & Growth Rates
Alpha Tau Medical's revenue in the last 12 month grew by 1430%.
Alpha Tau Medical's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.3M for the same period.
Alpha Tau Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1430% | XXX | β | XXX | XXX | XXX |
| EBITDA Margin | (11594%) | XXX | β | XXX | XXX | XXX |
| EBITDA Growth | 11% | XXX | 26% | XXX | XXX | XXX |
| Revenue per Employee | β | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | β | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 506% | XXX | β | XXX | XXX | XXX |
| G&A Expenses to Revenue | 2297% | XXX | β | XXX | XXX | XXX |
| R&D Expenses to Revenue | 8826% | XXX | β | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Alpha Tau Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Alpha Tau Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Bioventus | XXX | XXX | XXX | XXX | XXX | XXX |
| Synektik | XXX | XXX | XXX | XXX | XXX | XXX |
| Sunmax Biotechnology | XXX | XXX | XXX | XXX | XXX | XXX |
| MedicalSystem Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| SD Biosensor | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Alpha Tau Medical M&A Activity
Alpha Tau Medical acquired XXX companies to date.
Last acquisition by Alpha Tau Medical was on XXXXXXXX, XXXXX. Alpha Tau Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Alpha Tau Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAlpha Tau Medical Investment Activity
Alpha Tau Medical invested in XXX companies to date.
Alpha Tau Medical made its latest investment on XXXXXXXX, XXXXX. Alpha Tau Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Alpha Tau Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Alpha Tau Medical
| When was Alpha Tau Medical founded? | Alpha Tau Medical was founded in 2015. |
| Where is Alpha Tau Medical headquartered? | Alpha Tau Medical is headquartered in Israel. |
| How many employees does Alpha Tau Medical have? | As of today, Alpha Tau Medical has over 125 employees. |
| Who is the CEO of Alpha Tau Medical? | Alpha Tau Medical's CEO is Uzi Sofer. |
| Is Alpha Tau Medical publicly listed? | Yes, Alpha Tau Medical is a public company listed on Nasdaq. |
| What is the stock symbol of Alpha Tau Medical? | Alpha Tau Medical trades under DRTS ticker. |
| When did Alpha Tau Medical go public? | Alpha Tau Medical went public in 2022. |
| Who are competitors of Alpha Tau Medical? | Alpha Tau Medical main competitors are Bioventus, Synektik, Sunmax Biotechnology, MedicalSystem Technology. |
| What is the current market cap of Alpha Tau Medical? | Alpha Tau Medical's current market cap is $709M. |
| What is the current revenue of Alpha Tau Medical? | Alpha Tau Medical's last 12 months revenue is $381K. |
| What is the current revenue growth of Alpha Tau Medical? | Alpha Tau Medical revenue growth (NTM/LTM) is 1430%. |
| What is the current EV/Revenue multiple of Alpha Tau Medical? | Current revenue multiple of Alpha Tau Medical is 1707.0x. |
| Is Alpha Tau Medical profitable? | No, Alpha Tau Medical is not profitable. |
| What is the current EBITDA of Alpha Tau Medical? | Alpha Tau Medical has negative EBITDA and is not profitable. |
| What is Alpha Tau Medical's EBITDA margin? | Alpha Tau Medical's last 12 months EBITDA margin is (11594%). |
| What is the current EV/EBITDA multiple of Alpha Tau Medical? | Current EBITDA multiple of Alpha Tau Medical is (14.7x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.